Vivozon Pharmaceutical Co., Ltd. (KOSDAQ:082800)
South Korea · Delayed Price · Currency is KRW 4,180.00
+175.00 (4.37%)
At close: Feb 27, 2026
Vivozon Pharmaceutical Market Cap
Vivozon Pharmaceutical has a market cap or net worth of 207.12 billion as of February 27, 2026. Its market cap has decreased by -47.50% in one year.
Market Cap
207.12B
Enterprise Value
241.08B
Revenue
66.40B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,180.00
Market Cap Chart
Since November 18, 2005, Vivozon Pharmaceutical's market cap has increased from 72.45B to 207.12B, an increase of 185.88%. That is a compound annual growth rate of 5.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 207.12B | 3.21% |
| Dec 30, 2025 | 200.68B | -40.93% |
| Dec 30, 2024 | 339.73B | 134.89% |
| Dec 28, 2023 | 144.64B | -2.99% |
| Dec 29, 2022 | 149.09B | -19.87% |
| Dec 30, 2021 | 186.05B | -37.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DAE HWA Pharmaceutical | 291.48B |
| NOVAREX | 244.82B |
| OPTUS Pharmaceutical | 207.88B |
| Organoidsciences | 204.16B |
| GREEN CROSS WellBeing | 182.07B |
| High Tech Pharm | 168.00B |
| Kyung Dong Pharmaceutical | 157.61B |
| DongKoo Bio & Pharma | 151.17B |